6.55
前日終値:
$6.77
開ける:
$6.74
24時間の取引高:
233.42K
Relative Volume:
0.65
時価総額:
$438.14M
収益:
$555.06M
当期純損益:
$-39.48M
株価収益率:
-10.92
EPS:
-0.6
ネットキャッシュフロー:
$29.05M
1週間 パフォーマンス:
-5.62%
1か月 パフォーマンス:
-2.09%
6か月 パフォーマンス:
-10.40%
1年 パフォーマンス:
-51.73%
Bioventus Inc Stock (BVS) Company Profile
名前
Bioventus Inc
セクター
電話
(919) 474-6700
住所
4721 EMPEROR BOULEVARD, SUITE 100, DURHAM
BVS を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
BVS
Bioventus Inc
|
6.55 | 452.86M | 555.06M | -39.48M | 29.05M | -0.60 |
|
ABT
Abbott Laboratories
|
123.62 | 216.79B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
100.72 | 149.02B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
356.24 | 141.06B | 24.38B | 2.94B | 4.02B | 7.6145 |
|
MDT
Medtronic Plc
|
90.70 | 116.68B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
82.45 | 49.01B | 5.88B | 1.34B | 577.90M | 2.3455 |
Bioventus Inc Stock (BVS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-07 | 開始されました | Cantor Fitzgerald | Overweight |
| 2024-12-17 | アップグレード | JP Morgan | Underweight → Neutral |
| 2023-12-07 | アップグレード | Canaccord Genuity | Hold → Buy |
| 2023-08-09 | アップグレード | Craig Hallum | Hold → Buy |
| 2022-11-22 | ダウングレード | Craig Hallum | Buy → Hold |
| 2022-11-09 | ダウングレード | Canaccord Genuity | Buy → Hold |
| 2022-11-09 | ダウングレード | JP Morgan | Overweight → Underweight |
| 2022-03-15 | 開始されました | Craig Hallum | Buy |
| 2021-11-15 | 再開されました | Morgan Stanley | Overweight |
| 2021-11-10 | 再開されました | JP Morgan | Overweight |
| 2021-07-01 | ダウングレード | Goldman | Buy → Neutral |
| 2021-03-08 | 開始されました | Canaccord Genuity | Buy |
| 2021-03-08 | 開始されました | Goldman | Buy |
| 2021-03-08 | 開始されました | JP Morgan | Overweight |
| 2021-03-08 | 開始されました | Morgan Stanley | Overweight |
すべてを表示
Bioventus Inc (BVS) 最新ニュース
Bioventus Inc. stock prediction for this weekLong Setup & Accurate Entry/Exit Alerts - newser.com
Can Bioventus Inc. rally from current levelsWeekly Investment Summary & Fast Moving Trade Plans - newser.com
Will Bioventus Inc. stock deliver long term returnsMarket Growth Report & Reliable Price Breakout Alerts - newser.com
Will Bioventus Inc. stock maintain momentum in 2025July 2025 Intraday Action & AI Forecasted Entry and Exit Points - newser.com
Can Bioventus Inc. stock sustain free cash flow growth2025 Big Picture & Safe Capital Growth Trade Ideas - newser.com
Short interest data insights for Bioventus Inc.July 2025 PostEarnings & Weekly Top Gainers Trade List - newser.com
What the charts say about Bioventus Inc. todayRisk Management & Verified Short-Term Trading Plans - newser.com
Why Bioventus Inc. stock is trending among retail tradersBond Market & Capital Efficiency Focused Ideas - newser.com
How strong is Bioventus Inc. stock revenue growth2025 Fundamental Recap & Accurate Entry/Exit Alerts - newser.com
Developing predictive dashboards with Bioventus Inc. dataMarket Growth Summary & Weekly Breakout Watchlists - newser.com
Detecting price anomalies in Bioventus Inc. with AIInflation Watch & Technical Pattern Alert System - newser.com
Backtesting results for Bioventus Inc. trading strategiesEarnings Recap Summary & Safe Investment Capital Preservation Plans - newser.com
Should you wait for a breakout in Bioventus Inc.Quarterly Earnings Report & Risk Managed Investment Strategies - newser.com
Is Bioventus Inc. stock recession proofQuarterly Profit Report & AI Powered Market Entry Ideas - newser.com
Bioventus Inc. stock chart pattern explained2025 Breakouts & Breakdowns & Intraday High Probability Alerts - newser.com
Bioventus to Report Third Quarter of Fiscal Year 2025 Financial Results on November 4, 2025 - The Manila Times
Bioventus (NASDAQ: BVS) to report Q3 FY2025 before open; 8:30 a.m. ET call - Stock Titan
Bioventus Inc (BVS) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):